Engineering of therapeutic proteins production in Escherichia coli.
about
Decoding mechanisms by which silent codon changes influence protein biogenesis and functionThe unexhausted potential of E. coliFusion tags for protein solubility, purification and immunogenicity in Escherichia coli: the novel Fh8 systemMaltose-binding protein fusion allows for high level bacterial expression and purification of bioactive mammalian cytokine derivativesRefolding of a thermostable glyceraldehyde dehydrogenase for application in synthetic cascade biomanufacturingRecombinant production of medium- to large-sized peptides in Escherichia coli using a cleavable self-aggregating tagEfficient production of native lunasin with correct N-terminal processing by using the pH-induced self-cleavable Ssp DnaB mini-intein system in Escherichia coliSynthetic Microbial Ecology: Engineering Habitats for Modular Consortia.New tricks of well-known aminoazoles in isocyanide-based multicomponent reactions and antibacterial activity of the compounds synthesized.Expression, isolation, and purification of soluble and insoluble biotinylated proteins for nerve tissue regeneration.Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements.Synthetic sugar cassettes for the efficient production of flavonol glycosides in Escherichia coli.Ribosome-Mediated Incorporation of Dipeptides and Dipeptide Analogues into Proteins in Vitro.Role of Recombinant DNA Technology to Improve LifeProduction of recombinant immunotherapeutics for anticancer treatment: the role of bioengineering.Optimized and enhanced DNA plasmid vector based in vivo construction of a neutralizing anti-HIV-1 envelope glycoprotein Fab.Increasing recombinant protein production in Escherichia coli through metabolic and genetic engineering.Plant biofarming: novel insights for peptide expression in heterologous systems.Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells.Oxidation of therapeutic proteins and peptides: structural and biological consequences.Glyco-engineering for biopharmaceutical production in moss bioreactors.Post-production protein stability: trouble beyond the cell factory.Platelet-rich plasma and its derivatives as promising bioactive materials for regenerative medicine: basic principles and concepts underlying recent advances.Antibody Engineering for Pursuing a Healthier FutureTools to cope with difficult-to-express proteins.Process development of a human recombinant diabody expressed in E. coli: engagement of CD99-induced apoptosis for target therapy in Ewing's sarcoma.Expression of recombinant Ara h 6 in Pichia pastoris but not in Escherichia coli preserves allergic effector function and allows assessment of specific mutations.Dengue patients exhibit higher levels of PrM and E antibodies than their asymptomatic counterparts.Expression of granulocyte colony stimulating factor (GCSF) in Hansenula polymorpha.Phosphorylation of Ser-204 and Tyr-405 in human malonyl-CoA decarboxylase expressed in silkworm Bombyx mori regulates catalytic decarboxylase activity.Improvement in the production of the human recombinant enzyme N-acetylgalactosamine-6-sulfatase (rhGALNS) in Escherichia coli using synthetic biology approaches.A glycosylated recombinant subunit candidate vaccine consisting of Ehrlichia ruminantium major antigenic protein1 induces specific humoral and Th1 type cell responses in sheep.Rhizobium etli asparaginase II: an alternative for acute lymphoblastic leukemia (ALL) treatment.Obtention and characterization of the recombinant simian Interleukin-15 in Escherichia coli for the preclinical assessment of an IL-15-based therapeutic vaccine.A convenient method for hTfR1 inclusion body purification.Towards structure-based protein drug design.Patient preferences in the treatment of hemophilia A: impact of storage conditions on product choice.N-Terminal methionine processing by the zinc-activated Plasmodium falciparum methionine aminopeptidase 1bImproving Immunotherapy Through Glycodesign
P2860
Q26821951-89CF82FA-6204-427D-A61B-95A36C3D060FQ26860229-0D8AA777-51C1-42CC-B747-F204F999D77FQ27001688-0AF5BA8D-5A28-4286-8D86-3535B1399C9FQ28542860-98F53906-FBDA-4175-B5CF-1691030C3043Q28673623-B6B63D46-5602-45C9-A791-CC5BAA3B4D5AQ28831200-EA1D4197-0971-4C96-BA77-66A20201C3B2Q30104589-DE0DB014-C28A-47E3-8C01-6A98C16DC62DQ33804367-BD89D1AC-A403-40E0-92ED-DB6B9D76952CQ33824188-C72AD325-2D74-41A7-AB81-CEE4375B8D22Q33872665-E63EF23C-4F96-4759-99EF-3D3BEB03BFF3Q34247760-20E5536A-5E0E-4780-8075-F44BC8284166Q35693111-62AECB88-4F70-431D-8A77-48EE131091F5Q35753550-0CEEAD0B-4C61-40B3-A008-BBE3588DF916Q36239956-7E091B53-FF95-4B62-A065-2F1AFD87AA58Q37269115-466FFC04-6141-4C3B-92E0-DABE46E12F76Q37530545-4CB0AB91-6B9F-48C8-932D-4D1182455EF7Q37928986-FE0DE69C-84FE-49B9-BDFA-41D3D47D8CD5Q38063510-73A38501-8EB0-475C-9ECB-9C61FDB0B28EQ38079490-EB28D65F-28A2-410C-951D-B0D0F0053B3EQ38142887-0423BC3C-269E-413F-BD1B-5178D2CD3404Q38234961-10E33473-FB4B-46EE-8B69-C5CDA79B6317Q38264351-D159BF57-658C-4F85-8151-A54BFB78B053Q38514835-631FF4E3-3302-43DB-B1A2-1C01706E139AQ38731632-E457CA42-80C1-488A-80CD-3DEDC79B36D3Q38808506-2600DED9-EA6F-429F-9483-666137236F8FQ38810472-FB0938CE-E9F6-4E15-ADEB-C1AA843DF77CQ39329667-69DA9DE0-C6A3-48F1-8F25-ED4EF21C27A6Q39615846-D634CD2C-34F6-4B91-AB04-958FF23852B1Q40244997-18730497-EBD9-4616-A0E6-F0693A61E795Q40906949-73C741F9-3536-497C-8782-A4C109DE8E5EQ41062293-7985AD9A-7C79-4F8C-95C2-54F848171401Q42366235-4C762A2F-DCAD-44BB-9C62-A96CDB7DCF3CQ42770604-0D0CE90F-3369-47EA-882C-BBE8E36A75BAQ47785246-37148C04-9F87-46E3-AF2E-478F24B43084Q48551705-897FF95B-D854-46F6-826C-30F699468238Q51530156-0F4BFE86-EAE5-4EF5-B735-99BBEA03B5D1Q54965788-63176CBC-DDF5-41F4-8CB3-CD1891CC108AQ56784732-540F1569-D714-44BD-A5FD-48754525372FQ59132146-AC901E8C-8A09-4311-9781-837A1EB740C2
P2860
Engineering of therapeutic proteins production in Escherichia coli.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Engineering of therapeutic proteins production in Escherichia coli.
@en
Engineering of therapeutic proteins production in Escherichia coli.
@nl
type
label
Engineering of therapeutic proteins production in Escherichia coli.
@en
Engineering of therapeutic proteins production in Escherichia coli.
@nl
prefLabel
Engineering of therapeutic proteins production in Escherichia coli.
@en
Engineering of therapeutic proteins production in Escherichia coli.
@nl
P2860
P921
P1476
Engineering of therapeutic proteins production in Escherichia coli.
@en
P2093
Mariusz Kamionka
P2860
P304
P356
10.2174/138920111794295693
P577
2011-02-01T00:00:00Z